You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Jordan Patent: 2464


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Jordan Patent: 2464

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jul 7, 2028 Janssen Prods YONDELIS trabectedin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Jordan Drug Patent JO2464

Last updated: July 29, 2025


Introduction

Patent JO2464, registered in Jordan, pertains to a pharmaceutical invention likely aimed at providing protection for a novel drug or formulation. An in-depth review of its scope, claims, and the overall patent landscape is essential for stakeholders involved in licensing, competitive analysis, or R&D strategy. This analysis synthesizes available patent documentation, claims structure, and contextualizes the patent within the broader pharmaceutical patent ecosystem.


Patent Overview and Basic Details

Patent Number: JO2464
Jurisdiction: Jordan
Filing Date: [Given date or estimated, if known]
Publication Date: [Estimated or actual]
Applicant/Assignee: [In case of known entity]
Inventor(s): [If available]
Patent Type: Likely utility patent based on pharmaceutical nature

Note: As detailed particulars of JO2464 are not publicly disclosed in the initial prompt, this analysis assumes a typical patent for a pharmaceutical compound or formulation based on common patent strategies in this sector.


Scope of the Patent

Patent JO2464's scope is primarily defined by its claims, which delineate the legal limits of protection. The scope typically covers:

  • Pharmaceutical Compound(s): The active ingredient(s), including novel chemical entities, derivatives, or salts.
  • Formulation Attributes: Specific compositions, excipients, or delivery mechanisms.
  • Method of Use: Indications, treatment protocols, or administration routes.
  • Manufacturing Process: Any novel synthesis or purification process.

The scope, therefore, likely encompasses a combination of these elements, with claims tailored to balance broad coverage (such as composition claims) and narrow specificity (such as method claims).


Claims Analysis

Types of Claims:

  1. Independent Claims: Define the core invention. For a pharmaceutical patent, this could be a chemical compound, a pharmaceutical composition, or a novel delivery method.
  2. Dependent Claims: Narrow down the independent claims, adding specific details such as dosage, formulation specifics, or optional additives.

Typical Claim Features:

  • Chemical Structure: If the patent covers a novel compound, the claims often include a detailed chemical structure, possibly represented via Markush groups.
  • Compound Parameters: Molecular weight, stereochemistry, or specific substitutions.
  • Pharmaceutical Formulations: Claims covering tablets, capsules, injectables, or transdermal patches.
  • Method of Treatment: Including claims that specify treatment of particular diseases or conditions.
  • Manufacturing Steps: If proprietary synthesis processes are involved, claims may encompass these steps.

Claim Robustness & Breadth:

Pharmaceutical patents often face challenges regarding claim breadth, balancing broad protection with the novelty and non-obviousness requirements. In Jordan, patent examination considers local patent laws aligned with TRIPS, which emphasize these criteria.

Given the typical structure, JO2464's claims likely focus on:

  • A novel chemical entity or salt.
  • Its specific pharmacological use.
  • Formulations with particular excipient combinations.
  • Methods of administering or synthesizing the compound.

Patent Landscape and Competitive Context

1. Regional Patent Environment:

Jordan's pharmaceutical patent landscape reflects a mix of locally filed and foreign patents. The Jordan Patent Law aligns with international standards, enabling patentability of pharmaceuticals if novelty, inventive step, and industrial applicability are satisfied.

2. International Patent Families & Similarities:

  • Global filing strategies: Companies often file in Jordan following broader regional filings, especially within the Middle East and North Africa (MENA) region.
  • Similar patents: Comparable patents exist in jurisdictions such as EP, US, and other Arab countries, indicating a thematic cluster of innovations around specific drug classes (e.g., kinase inhibitors, biologics).

3. Patent Thickets & Freedom to Operate:

  • Drugs with existing patent families in Jordan may require licensing or patent clearance.
  • If JO2464 claims a novel chemical entity, it may stand as a core patent, but if it covers a formulation or method of use, the landscape could be crowded with overlapping prior arts.

4. Patent Litigation & Enforcement:

  • While Jordan's enforcement mechanisms are evolving, patent disputes often focus on infringement claims related to manufacturing or distribution.

5. Strategic Implications:

  • Patent Expiry: Many pharmaceutical patents span 20 years from filing, but exclusivity can be affected by patent term adjustments.
  • Innovation Clusters: The landscape around JO2464 likely includes other compounds targeting similar pathways or diseases, shaping competitive positioning.

Implications for Industry Stakeholders

  • For Innovators: JO2464 potentially signifies expansion into Jordan’s pharmaceutical market, provided patent claims are robust and enforceable.
  • For Competitors: The scope of claims dictates whether similar compounds or formulations can be developed without infringement.
  • For Legal & Patent Professionals: A detailed claim chart analysis is paramount to assess infringement risks and the patent’s enforceability.

Concluding Remarks

Patent JO2464 appears to serve as a strategic intellectual property asset within Jordan’s pharmaceutical patent landscape. Its scope, hinged on detailed claims, likely covers a specific active pharmaceutical ingredient, formulation, or method of use with potential regional or global relevance. Understanding its claim breadth and its interplay within regional and international patent rights is vital for R&D, licensing, and compliance decisions.


Key Takeaways

  • Scope Clarity: The patent's legal scope hinges on well-drafted claims covering the core invention while maintaining an appropriate balance against prior arts.
  • Landscape Positioning: JO2464 exists within a competitive environment shaped by regional patents and potential international filings.
  • Strategic Value: The patent provides an opportunity for market exclusivity in Jordan, especially if it covers a novel compound or formulation with substantial therapeutic advantages.
  • Legal & Business Considerations: Continuous monitoring of patent families and potential overlaps is essential to avoid infringement or to identify licensing opportunities.
  • Future Directions: Patent life extensions, supplementary filings (e.g., divisional), and geographical expansion can enhance patent portfolio strength.

FAQs

1. What is the typical scope of pharmaceutical patents in Jordan?
Pharmaceutical patents in Jordan generally cover active compounds, formulations, methods of manufacture, and therapeutic uses, with claims carefully crafted to ensure enforceability and regional relevance.

2. How does Jordan’s patent law influence pharmaceutical patent claims?
Jordan’s patent law aligns with TRIPS standards, requiring novelty, inventive step, and industrial applicability. These criteria influence how broadly claims can be drafted and enforced.

3. What strategies can companies use to strengthen patent protection around JO2464?
Filing supplementary claims, pursuing regional patent filings (e.g., in neighboring Arab countries), and securing data exclusivity can enhance protection.

4. Are there known overlaps with international patents related to JO2464?
A detailed patent landscape analysis would be necessary but is common for similar drugs elsewhere; overlaps often exist in well-studied therapeutic classes.

5. What are key considerations for licensing or commercialization based on JO2464's patent status?
Understanding the scope and validity of claims, potential patent expiry, and existing prior arts are critical for licensing negotiations and market strategy.


References

  1. Jordan Patent Law, 2001.
  2. World Intellectual Property Organization (WIPO). Patent Landscape Reports.
  3. Local patent databases for Jordan.
  4. International patent databases (e.g., Espacenet, USPTO, EPO).

Note: Due to limited publicly available specifics on patent JO2464, this analysis is based on typical pharmaceutical patent features and regional patent law practices.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.